Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
NCT00160212
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Daglutril
Sponsor
Solvay Pharmaceuticals